International consortium identifies biomarkers for cardiovascular disease in diabetes by Jen Brogan | Jan 30, 2024 | News | 0 Type 2 diabetes is estimated to affect 462 million people worldwide Read More
Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients by Lucy Parsons | Jul 14, 2021 | News | 0 The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study Read More
FDA refuses Novo Nordisk’s once-weekly semaglutide by Lucy Parsons | Mar 24, 2021 | News | 0 Company had been aiming for approval in type 2 diabetes Read More
Lilly’s tirzepatide claims head-to-head trial win against injectable semaglutide by Lucy Parsons | Mar 5, 2021 | News | 0 Tirzepatide demonstrated superior A1C and body weight reduction in type 2 diabetes Read More